The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant and adjuvant (neoadj-adj) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants with cisplatin-ineligible muscle-invasive bladder cancer (MIBC): An analysis of clinically relevant subgroups in KEYNOTE-905.
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)
 
Christof Vulsteke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Atheneum; Bayer; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; ipsen; Janssen; LEO Pharma; MSD; Pfizer
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Roche
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Alejo Rodriguez-Vida
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson/Janssen; Merck KGaA; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Johnson & Johnson/Janssen; MSD Oncology
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Zhentao Zhang
Honoraria - Apliate Health; Astellas Pharma; AstraZeneca; Curio Science; DAVA Pharmaceuticals; Gilead Cornerstones; Pfizer
Consulting or Advisory Role - Astellas Amgen BioPharama; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Aveo Onlivy; Pfizer
 
Ja Hyeon Ku
No Relationships to Disclose
 
Judit Olah
No Relationships to Disclose
 
Anna Kolodziej
No Relationships to Disclose
 
Maksym Sabadash
No Relationships to Disclose
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Janssen; Lilly Medical; Merck; Merck Serono; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck Serono; Pfizer/EMD Serono; Roche
 
Nimira Alimohamed
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; EMD Serono; Gilead Sciences; Janssen Oncology; Merck; Pfizer
Research Funding - AstraZeneca Canada (Inst); EMD Serono (Inst)
 
Peter O'Donnell
Honoraria - Abbvie; Advarra; American Society for Clinical Pharmacology & Therapeutics; AmerisourceBergen; Astellas Pharma; Axiom Healthcare Strategies; CLD, Inc.; Curio Science; EMD Serono; Health Advances; ImmunityBio; IntrinsiQ; Loxo/Lilly; Med IQ; MedLearning Group; Medscape; Merck; Parexel International Corp; Pfizer; Research to Practice; Thermo Fisher Scientific; Vaniam Group
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen (Inst); Loxo/Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Expert Testimony - Hart Wagner LLP
Travel, Accommodations, Expenses - Astellas Pharma; Curio Science; Merck; NAMCP; Pfizer
Other Relationship - Dragonfly Therapeutics; Duke University; G1 Therapeutics; Janssen; Nektar
 
Oleksandr Lychkovsky
No Relationships to Disclose
 
Girish Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; Ferring; Knight Pharmaceuticals; Photocure; Protara Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; enGene; Ferring; Janssen Oncology; Johnson & Johnson/Janssen; Merck; Novartis; Pfizer; Theralase; Verity Pharmaceuticals
Research Funding - Johnson & Johnson/Janssen (Inst)
Travel, Accommodations, Expenses - Ferring
 
Jasmine Lichfield
Employment - Astellas Pharma; MSD
Stock and Other Ownership Interests - MSD
 
Changting Meng
Employment - Karyopharm Therapeutics; Pfizer; Seagen
Stock and Other Ownership Interests - Karyopharm Therapeutics; Pfizer; Seagen
Travel, Accommodations, Expenses - Karyopharm Therapeutics; Pfizer; Seagen
 
David Huang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chethan Ramamurthy
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Blanca Homet Moreno
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Pongwut Danchaivijitr
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Merck; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Merck (Inst); Roche (Inst)